2022 -- S 2071  | |
========  | |
LC003630  | |
========  | |
STATE OF RHODE ISLAND  | |
IN GENERAL ASSEMBLY  | |
JANUARY SESSION, A.D. 2022  | |
____________  | |
A N A C T  | |
RELATING TO INSURANCE -- INSURANCE COVERAGE FOR MENTAL ILLNESS AND  | |
SUBSTANCE ABUSE  | |
  | |
Introduced By: Senators Seveney, Cano, Pearson, Coyne, and Miller  | |
Date Introduced: January 25, 2022  | |
Referred To: Senate Health & Human Services  | |
It is enacted by the General Assembly as follows:  | |
1  | SECTION 1. Section 27-38.2-1 of the General Laws in Chapter 27-38.2 entitled "Insurance  | 
2  | Coverage for Mental Illness and Substance Abuse" is hereby amended to read as follows:  | 
3  | 27-38.2-1. Coverage for treatment of mental health and substance use disorders.  | 
4  | (a) A group health plan and an individual or group health insurance plan shall provide  | 
5  | coverage for the treatment of mental health and/or substance use disorders under the same terms  | 
6  | and conditions as that coverage is provided for other illnesses and diseases.  | 
7  | (b) Coverage for the treatment of mental health and/or substance use disorders shall not  | 
8  | impose any annual or lifetime dollar limitation.  | 
9  | (c) Financial requirements and quantitative treatment limitations on coverage for the  | 
10  | treatment of mental health and/or substance use disorders shall be no more restrictive than the  | 
11  | predominant financial requirements applied to substantially all coverage for medical conditions in  | 
12  | each treatment classification.  | 
13  | (d) Coverage shall not impose non-quantitative treatment limitations for the treatment of  | 
14  | mental health and/or substance use disorders unless the processes, strategies, evidentiary standards,  | 
15  | or other factors used in applying the non-quantitative treatment limitation, as written and in  | 
16  | operation, are comparable to, and are applied no more stringently than, the processes, strategies,  | 
17  | evidentiary standards, or other factors used in applying the limitation with respect to  | 
18  | medical/surgical benefits in the classification.  | 
  | |
1  | (e) The following classifications shall be used to apply the coverage requirements of this  | 
2  | chapter: (1) Inpatient, in-network; (2) Inpatient, out-of-network; (3) Outpatient, in-network; (4)  | 
3  | Outpatient, out-of-network; (5) Emergency care; and (6) Crisis stabilization medications; and (7)  | 
4  | Prescription drugs.  | 
5  | (f) Medication-assisted treatment or medication-assisted maintenance services of substance  | 
6  | use disorders, opioid overdoses, and chronic addiction, including methadone, buprenorphine,  | 
7  | naltrexone, all federally-approved medications or other clinically appropriate medications, is  | 
8  | included within the appropriate classification based on the site of the service.  | 
9  | (g) Payors shall rely upon the criteria of the American Society of Addiction Medicine when  | 
10  | developing coverage for levels of care for substance use disorder treatment.  | 
11  | (h) Patients with substance use disorders shall have access to evidence-based, non-opioid  | 
12  | treatment for pain, therefore coverage shall apply to medically necessary chiropractic care and  | 
13  | osteopathic manipulative treatment performed by an individual licensed under ยง 5-37-2.  | 
14  | (i) Parity of cost-sharing requirements. Regardless of the professional license of the  | 
15  | provider of care, if that care is consistent with the provider's scope of practice and the health plan's  | 
16  | credentialing and contracting provisions, cost-sharing for behavioral health counseling visits and  | 
17  | medication maintenance visits shall be consistent with the cost-sharing applied to primary care  | 
18  | office visits.  | 
19  | (j) The coverage required by this section shall include at minimum ninety (90) days of  | 
20  | residential or inpatient services for mental health and/or substance use disorders for American  | 
21  | Society of Addiction Medicine levels of care 3.1 and 3.3.  | 
22  | SECTION 2. This act shall take effect on April 1, 2022, or upon passage, whichever date  | 
23  | occurs later in time.  | 
========  | |
LC003630  | |
========  | |
  | LC003630 - Page 2 of 3  | 
EXPLANATION  | |
BY THE LEGISLATIVE COUNCIL  | |
OF  | |
A N A C T  | |
RELATING TO INSURANCE -- INSURANCE COVERAGE FOR MENTAL ILLNESS AND  | |
SUBSTANCE ABUSE  | |
***  | |
1  | This act would require insurance coverage for at minimum ninety (90) days of residential  | 
2  | or inpatient services for mental health and/or substance use disorders for American Society of  | 
3  | Addiction Medicine levels of care 3.1 and 3.3.  | 
4  | This act would take effect on April 1, 2022, or upon passage, whichever date occurs later  | 
5  | in time.  | 
========  | |
LC003630  | |
========  | |
  | LC003630 - Page 3 of 3  |